| [1] Jiang, P.; Dai, W.X.; Yan, S.K.; Chen, Z.L.; Xu, R.L.; Ding, J.M.; Xiang, L.; Wang, S.P.; Liu, R.H.; Zhang, W.D. Biomarkers in the early period of acute myocardial infarction in rat serum and protective effects of Shexiang Baoxin Pill using a metabolomic method. J Ethnopharma-cology. 2011, 138, 530-536.
[2] Deten, A.; Zimmer, H. Heart function and cytokine expression is similar in mice and rats after myocardial infarction but differences occur in TNF-α expression. Pflug. Arch. Eur. J. Phy. 2002, 445, 289-296.
[3] Xu, H.; Yao, Y.W.; Su, Z.L.; Yang, Y.B.; Kao, R.; Martin, C.M.; Rui, T. Endogenous HMGB1 contributes to ischemia-reperfusion-induced myocardial apoptosis by potentiating the effect of TNF-α/JNK. Am. J. Physiol-Heart C. 2011, 300, H913-H921.
[4] Han, S.Y.; Li, H.X.; Bai, C.C.; Wang, L.; Tu, P.F. Component analysis and free radical-scavenging potential of Panax notoginseng and Carthamus tinctorius extracts. Chem. Biodivers. 2010, 7, 383-391.
[5] Kaga S.; Zhan, L.J.; Matsumoto, M.; Maulik, N. Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J. Mol. Cell Cardiol. 2005, 39, 813-822.
[6] Yu, Q.; Zeng, K.W.; Ma, X.L.; Song, F.J.; Jiang, Y.; Tu, P.F.; Wang, X.M. Resokaempferol-mediated anti-inflammatory effects on activated macrophages via the inhibition of JAK2/STAT3, NF-κB and JNK/p38 MAPK signaling pathways. Int Immunopharmacol. 2016, 38, 104-114.
[7] Wang, L.C.; Zhang, W.S.; Liu, Q.; Li, J.; Alolga, R.N.; Liu, K.; Liu, B.L.; Li, P.; Qi, L.W. A standardized notoginseng extract exerts cardioprotection by attenuating apoptosis under endoplasmic reticulum stress conditions. J. Funct. Foods. 2015, 16, 20-27.
[8] Han, S.Y.; Li, H.X.; Ma, X.; Zhang, K.; Ma, Z.Z.; Jiang, Y.; Tu, P.F. Evaluation of the anti-myocardial ischemia effect of individual and combined extracts of Panax notoginseng and Carthamus tinctorius in rats. J. Ethnopharmacol. 2013, 145, 722-727.
[9] Witteveen, S.A.; Hemker, H.C.; Hollaar, L.; Hermens, W.T. Quantitation of infarct size in man by means of plasma enzyme levels. Br. Heart J. 1975, 37, 795-803
[10] Suchalatha, S.; Shyamala Devi, C.S. Effect of arogh—A polyherbal formulation on the marker enzymes in isoproterenol induced myocardial injury. Indian J. Clin. Biohem. 2004, 19, 184-189.
[11] Xiong, J.; Xue, F.S.; Yuan, Y.J.; Wang, Q.; Liao, X.; Wang, W.L. Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardial ischemia reperfusion injury. Chin. Med. J. 2010, 123, 2720-2726.
[12] Frangogiannis, N.G.; Smith, C.W.; Entman, M.L. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002, 53, 31-47.
[13] De Haan, J.J.; Smeets, M.B.; Pasterkamp, G.; Arslan, F. Danger signals in the initiation of the inflammatory response after myocardial infarction. Mediators Inflamm. 2013, 2013, 206039.
[14] Ahn, J.; Kim, J. Mechanisms and consequences of inflammatory signaling in the myocardium. Curr Hypertens Rep. 2012, 14, 510-516.
[15] Ancey, C.; Corbi, P.; Froger, J.; Delwail, A.; Wijdenes, J.; Gascan, H.; Potreau, D.; Lecron, Secretion of IL-6, IL-11 and LIF by human cardiomyocytes in primary culture. J. Cytokine. 2002, 18, 199-205.
[16] Charles, A.D. Interleukin-1, Interleukin-1 Receptors and Interleukin-I Receptor Antagonist. Intern Rev Immunol. 1998, 16, 457-499.
[17] Nicholson, D.W.; Ali, A.; Thornberry, N.A.; Vaillancourt, J.P.; Ding, C.K.; Gallant, M.; Gareau, Y.; Griffin, P.R.; Labelle, M.; Lazebnik, Y.A. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature. 1995, 376, 37-43. |
>
>